Pre-eclampsia or eclampsia

O15_PRE_OR_ECLAMPSIA

preeclampsia: Preeclampsia is a hypertensive disorder of pregnancy that is characterized by new-onset hypertension with proteinuria presenting after 20 weeks of gestation, and depending on mild or severe forms may initially present with severe headache, visual disturbances, and hyperreflexia.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — O11, O14, O15 Hospital discharge: ICD-9 — 642[4-7] Hospital discharge: ICD-8 — 6370[349]\|63710\|63799\|66120 Cause of death: ICD-10 — O11, O14, O15 Cause of death: ICD-9 — 642[4-7] Cause of death: ICD-8 — 6370[349]\|63710\|63799\|66120 2 out of 7 registries used, show all original rules.	10022
4. Check minimum number of events None	10022
5. Include endpoints None	10022
6. Filter based on genotype QC (FinnGen only)	10022

Control definitions (FinnGen only)

Control exclude: O15_OEDEM_PROTUR_HYPERT

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF8

NAME	O15_PRE_OR_ECLAMPSIA
CONTROL_EXCLUDE	O15_OEDEM_PROTUR_HYPERT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	O11\|O140\|O141\|O149\|O150\|O151\|O152\|O159
HD_ICD_9	642[4-7]
HD_ICD_8	6370[349]\|63710\|63799\|66120
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	O11\|O140\|O141\|O149\|O150\|O151\|O152\|O159
COD_ICD_9	642[4-7]
COD_ICD_8	6370[349]\|63710\|63799\|66120
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pre-eclampsia or eclampsia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	68905	68905	-
Only index persons	67055	67055	-
Unadjusted period prevalence (%)
Whole population	1.97	1.97	-
Only index persons	2.47	2.47	-
Median age at first event (years)
Whole population	-	28.55	-
Only index persons	-	28.52	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10022	10022	-
Unadjusted period prevalence (%)	3.42	3.42	-
Median age at first event (years)	28.66	28.66	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9120: Matched controls
91200

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

O14.0

ICD-10 Finland

Mild to moderate pre-eclampsia

+∞

323.0

2468

O14.1

ICD-10 Finland

Severe pre-eclampsia

+∞

323.0

1012

6424A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]

+∞

323.0

1258

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

3.4

323.0

2230

7928

O14.9

ICD-10 Finland

Pre-eclampsia, unspecified

5135.6

323.0

1726

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

1224.6

323.0

2157

63701

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia

+∞

323.0

368

6425A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]

+∞

323.0

311

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

+∞

323.0

1975

6423A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]

+∞

323.0

322

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

6551.2

323.0

622

C07AG01

ATC

labetalol; systemic

55.5

323.0

632

122

63704

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia gravis

+∞

323.0

426

6424B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, SYNNYTYKSEN AIKANA]

+∞

323.0

351

205

Kela drug reimbursment

Chronic hypertension

3.1

290.8

1886

7067

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

3.9

281.2

1305

3763

I10

ICD-10 Finland

Essential (primary) hypertension

2.2

260.0

4078

24566

66120

ICD-8 Finland

Occipital presentation

+∞

255.4

244

O12.1

ICD-10 Finland

Gestational proteinuria

392.2

230.6

231

6425B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]

+∞

225.9

216

O11

ICD-10 Finland

Pre-eclampsia superimposed on chronic hypertension

+∞

203.9

195

8811

FHL

Cesarean section

3.3

200.1

1128

3737

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

2.8

198.2

1448

5722

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

2.8

194.0

1470

5934

63710

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Eclampsia

+∞

188.1

180

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

2.2

180.2

2286

12042

C09AA02

ATC

enalapril; systemic

2.7

173.2

1361

5580

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

3.0

173.2

1117

4044

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

171.1

1807

8692

63799

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Toxaemia, unspecified

+∞

169.3

162

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.5

168.5

1483

6482

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

168.0

1775

8534

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

6.3

154.7

432

710

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.4

145.8

760

2346

C08CA05

ATC

nifedipine; systemic

3.9

145.0

641

1727

6420X

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium

+∞

144.1

138

ZXD05

NOMESCO Finland

Urgent procedure

1.8

137.5

3031

19409

A10BA02

ATC

metformin; oral

2.1

136.6

1818

9606

63700

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Albuminuria (proteinuria)

+∞

135.7

130

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

4.1

135.4

559

1414

C08CA01

ATC

amlodipine; oral

2.0

127.3

2153

12471

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

1.9

126.2

2205

12920

Z39.2

ICD-10 Finland

Routine postpartum follow-up

2.0

121.6

1859

10332

O16

ICD-10 Finland

Unspecified maternal hypertension

130.8

120.4

129

W84

ICPC

Pregnancy high risk

3.4

119.2

621

1908

O60

ICD-10 Finland

Preterm labour and delivery

3.7

114.3

531

1486

A10AE04

ATC

insulin glargine; parenteral

3.0

112.8

725

2584

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

112.3

1045

4624

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

4.2

108.7

441

1094

T90

ICPC

Diabetes non-insulin dependent

2.1

104.2

1440

7628

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.1

104.2

632

2164

SPAT1262

SPAT

Handing over of treatment supplies

2.1

103.6

1314

6715

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

101.4

1305

6707

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.7

101.0

3015

20710

63702

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema

+∞

97.0

C07AB02

ATC

metoprolol; systemic

2.0

94.7

1316

6964

O80.8

ICD-10 Finland

Other single spontaneous delivery

2.7

92.2

680

2631

O12.0

ICD-10 Finland

Gestational oedema

54.6

90.4

108

SPAT1379

SPAT

Health check-up of pregnant person

1.9

90.1

1481

8346

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.7

89.0

420

1188

C07AB07

ATC

bisoprolol; oral

1.6

87.9

2947

20702

A10AE05

ATC

insulin detemir; parenteral

3.1

84.5

490

1621

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.8

81.3

367

1000

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.0

75.9

465

1595

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.4

75.8

386

1159

C09CA01

ATC

losartan; oral

1.8

75.5

1529

9203

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.9

73.7

1301

7468

XMA22

NOMESCO Finland

General examination of pregnant woman

2.2

73.7

848

4114

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

2.8

73.1

514

1927

63709

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia NUD

+∞

73.0

C09BA02

ATC

enalapril and diuretics; systemic

2.9

71.7

475

1714

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.5

71.6

266

605

MAC96

NOMESCO Finland

Other induction or advancement of labour

3.1

69.4

416

1406

A10AA01

ATC

3.6

69.2

327

925

A10AA02

ATC

3.5

68.7

335

972

T89

ICPC

Diabetes insulin dependent

3.1

67.9

396

1314

Z87.5

ICD-10 Finland

Personal history of complications of pregnancy, childbirth and the puerperium

5.6

67.7

206

377

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.9

66.2

1135

6434

E66.8

ICD-10 Finland

Other obesity

2.3

65.6

645

2903

W78

ICPC

Pregnancy

1.7

65.3

1786

11694

O30.0

ICD-10 Finland

Twin pregnancy

3.6

65.3

309

875

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

65.3

1624

10358

MAA00

NOMESCO Finland

Amniocentesis

3.1

65.3

387

1298

O10.9

ICD-10 Finland

Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium

+∞

64.6

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

63.1

1102

6276

O82.0

ICD-10 Finland

Delivery by elective caesarean section

2.2

62.8

669

3122

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.9

62.6

409

1462

6462A

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension

+∞

62.6

66180

ICD-8 Finland

Occipital presentation

3.5

61.4

302

883

SPAT1197

SPAT

Extensive health check-up of expecting family

1.7

61.2

1597

10300

40199

ICD-8 Finland

Essential benign hypertension

8.7

60.6

134

156

O12.2

ICD-10 Finland

Gestational oedema with proteinuria

+∞

60.5

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

3.2

60.3

328

1035

H04AA01

ATC

glucagon; nasal, parenteral

3.6

59.9

288

826

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.9

59.4

378

1330

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

1.9

59.0

884

4758

C03CA01

ATC

furosemide; systemic

1.7

58.9

1271

7746

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.8

58.6

261

703

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.0

58.1

246

634

B01AB05

ATC

enoxaparin; parenteral

1.5

57.8

2286

16345

C09CA06

ATC

candesartan; oral

1.6

56.3

1668

11103

C09DA01

ATC

losartan and diuretics; oral

2.1

55.8

669

3290

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.7

53.9

1281

8016

WX320

NOMESCO Finland

Spinalanesthesy

1.6

52.5

1787

12290

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.3

51.8

269

820

C02EA02

ATC

4.4

51.8

197

460

C08CA13

ATC

lercanidipine; oral

2.0

51.5

744

3939

SPAT1380

SPAT

Postpartum check-up

1.7

51.0

1151

7085

A10BK03

ATC

empagliflozin; oral

2.3

48.4

461

2034

SPAT1263

SPAT

Sampling

1.4

47.8

3562

28662

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.3

47.3

472

2132

C03AA03

ATC

hydrochlorothiazide; oral

2.1

47.1

570

2810

C08CA02

ATC

felodipine; oral

2.3

47.1

455

2024

C09AA05

ATC

ramipril; oral

1.7

46.6

1120

7005

O61.0

ICD-10 Finland

Failed medical induction of labour

4.2

45.8

181

439

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.5

45.8

387

1609

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

3.1

44.7

260

861

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

3.0

44.6

264

885

C02CB01

ATC

37.6

44.0

C02AC05

ATC

moxonidine; oral

3.1

44.0

247

799

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.8

43.8

192

512

A10AE06

ATC

insulin degludec; parenteral

3.0

43.6

265

905

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.6

43.5

1130

7213

A10BH01

ATC

sitagliptin; oral

2.1

43.3

499

2405

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

43.3

416

1842

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

43.1

1196

7769

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

42.3

367

1545

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

1.9

42.3

620

3294

C09DA06

ATC

candesartan and diuretics; oral

2.2

42.1

471

2242

A10BJ06

ATC

semaglutide; parenteral

2.9

41.8

266

936

C10AA01

ATC

simvastatin; oral

1.5

40.9

1968

14491

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.0

40.5

114

191

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.4

40.1

124

233

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

40.0

3379

27515

W85

ICPC

Gestational diabetes

2.1

39.9

485

2392

W92

ICPC

Compl labour/ delivery livebirth

2.7

39.7

290

1109

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

39.4

792

4684

J01DA01

ATC

[U] cefalexin; systemic

1.3

39.1

5468

48095

W81

ICPC

Toxaemia of pregnancy

43.8

39.0

H3603, E103

ICD-10 Finland

4.8

38.8

133

281

O10.1

ICD-10 Finland

Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium

+∞

38.6

SPAT1196

SPAT

Monitoring of normal pregnancy

1.7

38.2

856

5233

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.7

38.0

810

4876

A10BB12

ATC

glimepiride; oral

2.7

37.3

269

1024

J01DB01

ATC

cefalexin; oral

1.4

37.1

7170

66092

K85

ICPC

Elevated blood pressure

1.7

36.8

867

5374

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

4.7

36.4

126

269

H3600, E103

ICD-10 Finland

4.1

35.5

143

355

O99.80

ICD-10 Finland

The fear of childbirth

1.8

35.1

601

3374

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

2.6

34.2

267

1061

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.8

33.6

146

388

160

Kela drug reimbursment

exenatide

3.5

33.2

161

468

C10AA05

ATC

atorvastatin; oral

1.4

33.0

1840

13851

G47.3

ICD-10 Finland

Sleep apnoea

1.5

33.0

1254

8741

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

32.8

988

6525

A12BA01

ATC

potassium chloride; oral

3.1

32.6

187

614

6423B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, SYNNYTYKSEN AIKANA]

+∞

32.3

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

1.8

32.3

595

3420

C07AG02

ATC

carvedilol; oral

2.4

32.2

277

1161

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.1

31.8

180

588

A10BK01

ATC

dapagliflozin; oral

2.4

31.7

269

1121

A10BJ02

ATC

liraglutide; parenteral

3.1

31.7

183

605

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.1

31.5

127

316

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.6

31.4

988

6589

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.6

30.5

227

880

K86

ICPC

Hypertension uncomplicated

1.7

30.1

605

3569

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

30.0

369

1827

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.6

29.9

223

865

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.5

29.6

143

416

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

4.0

29.6

120

301

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

4.8

29.5

206

O15.0

ICD-10 Finland

Eclampsia in pregnancy

+∞

29.2

N02BE01

ATC

paracetamol; systemic, rectal

1.4

28.9

7400

69293

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

28.9

566

3313

H3601, E103

ICD-10 Finland

4.3

28.6

108

253

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

28.6

887

5888

Z30.2

ICD-10 Finland

Sterilization

1.5

28.2

1138

8015

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.7

28.2

201

760

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.2

28.2

152

481

WX307

NOMESCO Finland

Obstetric epidural analgesia

1.5

27.7

890

5957

SPAT1310

SPAT

Counselling related to known health issue

1.3

27.6

2435

19668

6440B

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]

2.7

27.3

196

745

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

27.3

1229

8852

6565A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,RASK AIK]

5.4

26.8

154

T82

ICPC

Obesity

2.0

26.8

371

1928

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

26.8

540

3192

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.0

26.6

172

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.4

26.6

1206

8691

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

26.5

1085

7658

65700

ICD-8 Finland

Occipital presentation

3.3

26.2

134

408

6461A

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Oedema or excessive weight gain in pregnancy, without mention of hypertension

+∞

26.0

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.9

26.0

399

2153

C10AA07

ATC

rosuvastatin; oral

1.4

25.2

1295

9554

ZXD00

NOMESCO Finland

Emergency procedure

2.2

25.2

274

1291

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.5

24.6

118

343

WX892

NOMESCO Finland

Monitored bed care

1.8

24.5

404

2237

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.3

24.4

224

974

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

24.3

392

2153

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.1

24.1

238

6427A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Pre-eclampsia or eclampsia superimposed on pre-existing hypertension[PRAE-ECL SEU ECL CUM HYPERT ART,ENNEN SYNNYTYSTÄ]

+∞

24.0

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.6

23.8

126

SPAT1301

SPAT

No procedures

1.3

23.6

2216

17979

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

23.4

709

4677

O84.2

ICD-10 Finland

Multiple delivery, all by caesarean section

4.5

23.3

185

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.5

22.9

107

305

6563B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, SYNNYTYKSEN AIKANA]

2.3

22.9

224

1004

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

2.2

22.9

227

1026

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

22.6

754

5080

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

22.6

3049

25907

WX290

NOMESCO Finland

Other blockade of nerve

1.2

22.6

3961

34725

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

22.6

2477

20505

A10BX07

ATC

[U] liraglutide; parenteral

3.6

22.5

102

284

O26.6

ICD-10 Finland

Liver disorders in pregnancy, childbirth and the puerperium

2.4

22.4

194

821

C09DA03

ATC

valsartan and diuretics; oral

2.1

22.4

251

1199

K02.1

ICD-10 Finland

Caries of dentine

1.2

22.0

4918

44254

ZXE00

NOMESCO Finland

One hour or less

1.3

22.0

3197

27387

C09CA03

ATC

valsartan; oral

1.7

22.0

431

2525

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

1.9

21.9

330

1771

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.4

21.9

106

311

6565B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,SYNN AIK]

6.6

21.8

C07FB02

ATC

metoprolol and felodipine; systemic

2.9

21.8

132

454

O21.9

ICD-10 Finland

Vomiting of pregnancy, unspecified

2.5

21.6

166

660

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

2.4

21.6

185

779

A08AB01

ATC

orlistat; oral

4.6

21.6

168

O14

ICD-10 Finland

Pre-eclampsia

115.3

21.6

O41.0

ICD-10 Finland

Oligohydramnios

2.2

21.6

218

995

W29

ICPC

Pregnancy symptom/complaint other

2.0

21.6

286

1465

Z39.1

ICD-10 Finland

Care and examination of lactating mother

2.1

21.5

236

1118

O30.00

ICD-10 Finland

Twin pregnancy with separate amniotic and chorionic sacs

4.9

21.5

147

O26.88

ICD-10 Finland

Other specified pregnancy-related conditions

2.5

21.3

173

709

J01CA08

ATC

pivmecillinam; oral

1.2

21.3

4346

38657

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.8

21.1

343

1890

E66

ICD-10 Finland

Obesity

1.8

21.1

380

2165

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

21.1

925

6607

M04AA01

ATC

allopurinol; systemic

1.8

21.0

357

1997

C09AA03

ATC

lisinopril; oral

2.2

20.9

221

1029

H36.01

ICD-10 Finland

Diabetic maculopathy

4.1

20.9

197

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

20.9

758

5205

Y6099

ICD-8 Finland

Prenatal care and observation

1.7

20.7

426

2533

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

20.4

3592

31370

C07AB03

ATC

atenolol; systemic

2.0

20.3

255

1278

WX110

NOMESCO Finland

Local anesthesy

1.2

20.2

5930

54724

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.7

20.2

238

Z3232

NOMESCO Finland

Midwife

1.4

20.2

994

7258

C07BB07

ATC

bisoprolol and thiazides; systemic

2.1

20.1

232

1120

C03BA11

ATC

indapamide; oral

2.6

20.0

152

601

R51.80

ICD-10 Finland

Headache

1.4

19.8

1270

9697

N02AX02

ATC

tramadol; systemic, rectal

1.3

19.7

2854

24351

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

19.7

2559

21557

6542B

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, SYNNYTYKSEN AIKANA]

2.8

19.6

125

446

A10AA03

ATC

4.0

19.6

195

O02.1

ICD-10 Finland

Missed abortion

1.5

19.5

602

3984

SPAT1097

SPAT

Recording of ECG

1.5

19.2

794

5599

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

2.7

19.2

131

487

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

19.1

2078

17111

R80

ICD-10 Finland

Isolated proteinuria

5.0

19.1

122

C01DA14

ATC

isosorbide mononitrate; oral

1.8

19.1

340

1932

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

19.1

104

335

CKC12

NOMESCO Finland

Photocoagulation of retina

2.0

19.0

262

1362

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

19.0

4503

40485

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.9

19.0

117

409

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

18.9

903

6549

25009

ICD-8 Finland

Diabetes mellitus, Unspecified

5.1

18.8

116

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.3

18.7

1560

12389

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

18.5

1552

12337

J01AA02

ATC

doxycycline; systemic

1.2

18.4

6581

61667

C07AB08

ATC

celiprolol; oral

2.9

18.4

113

394

SPAT1153

SPAT

Removal of sutures

1.3

18.3

2064

17061

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.9

18.3

114

402

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

3.5

18.2

244

A10BX04

ATC

[U] exenatide; parenteral

3.8

18.2

209

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

18.2

597

4006

A10BD07

ATC

metformin and sitagliptin; systemic

2.1

17.9

195

922

162

Kela drug reimbursment

liraglutide

3.4

17.9

248

J01FF01

ATC

clindamycin; systemic

1.3

17.7

1951

16071

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

17.6

3152

27444

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

17.5

990

7393

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

17.4

1547

12381

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

17.4

2239

18791

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

17.3

1058

8005

LGA10

NOMESCO Finland

Sterilisation by destruction or division of Fallopian tubes

2.7

17.2

121

460

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

17.2

399

2456

M54.5

ICD-10 Finland

Low back pain

1.2

17.1

2613

22346

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

17.1

4999

45678

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.7

17.0

118

445

C10AX09

ATC

ezetimibe; oral

1.6

16.9

466

3000

ACC51

NOMESCO Finland

Release of median nerve

1.5

16.8

559

3762

8221

FHL

Sterilization of the laparotomy pathway

1.8

16.8

298

1695

O63.0

ICD-10 Finland

Prolonged first stage (of labour)

1.9

16.7

235

1235

6426A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Eclampsia[ECLAMPSIA , ENNEN SYNNYTYSTÄ]

+∞

16.7

MWE00

NOMESCO Finland

Reoperation for deep haemorrhage in obstetric surgery

6.9

16.6

LGA20

NOMESCO Finland

Sterilisation by constriction of Fallopian tubes

2.5

16.5

127

508

O46.0

ICD-10 Finland

Antepartum haemorrhage with coagulation defect

16.3

16.5

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

16.4

2008

16734

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

16.2

488

3208

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.9

16.2

335

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

16.2

3233

28403

V230A

ICD-9 Finland

Supervision of high-risk pregnancy, Pregnancy with history of infertility

2.5

16.0

120

475

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.3

16.0

139

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

15.9

1273

10029

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.7

15.9

183

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

15.8

1167

9084

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

15.8

1961

16351

6542A

ICD-9 Finland

Abnormality of organs and soft tissues of pelvis, Previous Caesarean delivery[CICATRIX UTERI POSTOPERATIVA, RASKAUDEN AIKANA]

3.8

15.8

179

SPAT1254

SPAT

Administration of medicine

1.4

15.7

779

5683

C03DA01

ATC

spironolactone; oral

1.6

15.7

447

2904

O72.2

ICD-10 Finland

Delayed and secondary postpartum haemorrhage

2.1

15.7

176

844

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

15.7

672

4772

O15.1

ICD-10 Finland

Eclampsia in labour

+∞

15.6

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

15.5

864

6434

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.9

15.5

311

C08DB01

ATC

diltiazem; oral

2.1

15.3

171

819

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.5

15.2

116

464

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.5

15.2

206

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

15.1

4641

42377

J01CA04

ATC

amoxicillin; systemic

1.2

15.0

7137

67911

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

5.8

15.0

C08CA10

ATC

nilvadipine; oral

2.9

15.0

328

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

15.0

1180

9268

A10BG03

ATC

pioglitazone; oral

2.5

15.0

113

447

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

1.6

15.0

425

2757

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.9

14.9

158

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.3

14.9

132

569

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

14.8

2775

24159

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

14.8

408

2629

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

14.8

3132

27597

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

14.8

192

978

A10AB06

ATC

insulin glulisine; parenteral

3.3

14.8

221

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.8

14.6

166

SPAT1189

SPAT

Other ultrasound examination during pregnancy

1.7

14.5

318

1930

M79.6

ICD-10 Finland

Pain in limb

1.2

14.4

2746

23939

Y4300

ICD-8 Finland

Preventive sterilization, Legal sterilization, medical reasons (illness or physical injury)

2.2

14.4

139

625

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

14.4

6227

58528

A46

ICD-10 Finland

Erysipelas

1.5

14.3

580

4070

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

14.2

459

3070

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

14.2

102

395

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.1

14.1

251

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

1.6

14.1

386

2484

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

1.8

13.9

230

1281

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

13.9

151

714

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.3

13.9

129

571

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.7

13.9

261

1514

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.1

13.9

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

5.1

13.9

O35.8

ICD-10 Finland

Maternal care for other (suspected) fetal abnormality and damage

1.9

13.9

191

997

B01AC04

ATC

clopidogrel; oral

1.5

13.8

446

2986

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

2.6

13.7

379

TMW99

NOMESCO Finland

Other minor surgical procedure in obstetrics

2.6

13.6

101

397

O82.11

ICD-10 Finland

Childbirth with an emergency caesarean section in an emergency

2.3

13.5

125

550

O72.1

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3012516) Albumin [Mass/volume] in Urine

3483

17144

2.58

307.65

4.1

3.1

mg/l

369.9

535.9

1.46

2416

9652

(3009508) Creatinine [Moles/volume] in Urine

3666

19856

2.33

307.65

4.1

3.0

mmol/l

10.9

7.0

0.49

3211

16898

(3020682) Albumin/Creatinine [Ratio] in Urine

3620

17983

2.59

307.65

5.1

3.8

mg/mmol

25.6

7.0

39.56

2529

10369

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1401

6381

2.39

176.04

4.2

4.1

u/l

246.4

235.7

0.88

1339

6022

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

657

2227

3.09

146.97

3.1

1.6

g/l

1.2

1.5

17.71

592

1912

(3026493) Urate [Moles/volume] in Serum or Plasma

2896

18520

1.79

138.51

3.1

2.0

umol/l

2518.4

3018.8

0.39

2600

16234

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

536

2315

2.39

73.59

2.5

2.4

g/l

4.0

3.6

9.05

498

2186

(3013826) Glucose [Moles/volume] in Serum or Plasma

5304

43783

1.45

69.60

4.6

3.9

mmol/l

6.8

6.4

27.85

4844

40016

(3019550) Sodium [Moles/volume] in Serum or Plasma

9153

85089

1.87

67.09

13.9

11.2

mmol/l

139.5

139.7

15.91

8973

82892

(3023103) Potassium [Moles/volume] in Serum or Plasma

9171

85338

1.88

66.59

14.1

11.3

mmol/l

3.9

14.82

8974

82941

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

321

1134

2.89

66.17

2.8

2.4

ug/min

148.0

44.1

2.41

208

678

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

710

3651

2.02

62.80

1.9

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

777

4144

1.95

61.87

1.6

1.5

—

(3032080) INR in Blood by Coagulation assay

3301

25511

1.44

58.60

6.1

5.6

inr

1.1

0.79

1149

7954

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

597

2987

2.06

56.82

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2570

19385

1.44

50.44

2.2

1.7

mg/l

1.4

0.9

6.73

1994

14515

(3020876) Protein [Mass/time] in 24 hour Urine

157

425

3.74

49.98

2.9

1.7

g/24h

1.7

0.9

0.73

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1315

8723

1.58

47.79

1.6

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8083

74204

1.46

46.87

6.4

4.6

mmol/mol

40.6

37.9

100.50

7666

69576

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3974

32823

1.35

43.56

4.1

3.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3157

25188

1.37

43.17

3.0

2.7

ng/l

32.9

55.6

0.43

1745

12705

(3037467) Urinalysis macro (dipstick) panel - Urine

6604

58957

1.35

42.17

4.7

4.1

—

(3037121) Protein [Mass/volume] in Urine

442

2214

2.04

41.80

3.2

2.9

g/l

0.6

0.3

6.34

226

765

(3029937) Albumin [Presence] in Urine by Test strip

2814

22230

1.37

40.34

4.5

3.7

estimate

0.0

0.12

1106

8150

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

352

1666

2.15

38.67

3.8

2.8

mg/l

1.5

1.3

3.54

334

1556

(3026008) Bacteria identified in Urine by Culture

3082

24832

1.35

38.50

2.9

2.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2454

19086

1.38

38.41

1.8

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

4900

42315

1.31

37.10

4.0

3.3

estimate

0.0

1.15

1111

7987

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1367

9622

1.49

37.08

2.2

2.0

28.7

29.2

2.18

1310

9300

(3009261) Glucose [Presence] in Urine by Test strip

4949

42948

1.30

35.45

4.1

3.4

estimate

0.0

0.21

1088

8157

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9419

90314

1.71

35.42

14.9

12.1

umol/l

68.9

66.8

8.78

9413

90274

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1165

8043

1.51

34.57

6.7

4.8

mmol/l

1.1

1.0

2.87

1102

7516

(3021601) Nitrite [Presence] in Urine by Test strip

4907

42622

1.30

34.53

5.3

4.6

estimate

0.0

0.09

1135

8180

(3024561) Albumin [Mass/volume] in Serum or Plasma

3795

31924

1.30

33.79

5.2

4.2

g/l

35.4

36.5

27.69

3557

29698

(3034274) Bile acid [Moles/volume] in Serum --fasting

385

1999

1.96

32.89

2.4

2.1

umol/l

6.2

5.4

0.50

289

1459

(3041096) Erythrocytes [Presence] in Urine by Automated

2942

23983

1.32

32.66

3.3

2.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9479

91243

1.72

32.49

11.2

9.3

u/l

25.9

24.0

12.47

9272

88485

(3019832) Treponema pallidum Ab [Presence] in Serum

1842

14079

1.38

31.14

1.7

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6286

56768

1.29

30.98

4.7

4.0

e6/l

810.8

1924.5

1.63

610

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4681

40787

1.28

30.60

4.3

3.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2987

24849

1.29

27.39

2.7

2.4

u/l

53.5

57.2

1.54

2791

22912

(3036489) Thrombin time

513

3090

1.70

26.93

1.9

21.0

20.8

0.53

437

2595

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1590

12128

1.37

26.79

1.9

—

(3004775) Volume in Urine collected for unspecified duration

107

347

3.11

25.85

2.7

2.3

608.4

622.6

0.14

266

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4609

40608

1.25

25.55

5.5

5.6

umol/l

9.6

0.00

4353

38353

(3016750) Collection duration of Urine

260

3.44

25.47

2.6

2.2

min

507.4

500.4

0.30

217

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3328

28321

1.26

24.73

3.1

u/l

35.3

30.0

0.95

3155

27012

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

444

2636

1.72

24.58

2.1

2.0

91.8

95.9

2.88

410

2402

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1917

15223

1.32

24.42

2.8

2.5

ng/l

888.1

698.9

1.32

1602

12623

(3015736) pH of Urine

3755

32481

1.25

24.00

3.8

3.1

—

6.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8420

79967

1.33

23.25

11.4

9.8

ml/min/173m2

87.3

87.7

0.86

7138

65271

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7851

73871

1.29

23.16

5.0

4.4

pmol/l

14.6

14.4

3.52

7368

68929

(3020779) Urea [Moles/volume] in Serum or Plasma

685

4602

1.52

22.80

9.5

6.7

mmol/l

8.9

7.6

5.42

666

4414

(3013512) EKG study

2409

19898

1.28

22.49

3.5

3.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6769

62672

1.25

22.33

7.5

7.0

u/l

77.6

74.4

5.98

6412

59103

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1955

15737

1.30

22.29

1.7

1.6

pmol/l

56822757.6

36128946.8

0.46

1649

13416

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

416

2507

1.69

21.81

2.3

186.8

172.5

2.63

392

2360

(40761536) Microorganisms panel - Urine sediment

1011

7434

1.40

20.94

4.1

3.5

—

(3009343) pH of Capillary blood

517

3326

1.58

20.87

3.3

2.9

7.4

0.76

446

(3044889) 12 lead EKG panel

5977

54788

1.23

20.80

3.3

3.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1432

11135

1.33

20.80

3.2

mmol/l

0.9

0.8

6.09

1360

10379

(3022217) INR in Platelet poor plasma by Coagulation assay

953

6953

1.41

20.65

16.4

14.8

inr

1.2

1.1

0.72

156

1117

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8741

83775

1.34

20.31

4.5

3.8

mmol/l

1.5

1.6

104.25

8271

78826

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

520

3372

1.57

20.29

3.3

2.9

kpa

5.2

5.1

1.34

489

3132

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8700

83334

1.33

20.22

5.8

5.1

mu/l

1.7

2.1

4.09

8237

78390

(3007853) Bacteria identified in Skin by Aerobe culture

1200

9134

1.36

20.05

1.8

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

3070

26417

1.23

19.46

2.2

2.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

495

3206

1.57

19.42

3.3

2.8

mmol/l

1.7

0.11

367

2365

(3023368) Bacteria identified in Blood by Culture

1969

16138

1.27

19.11

3.9

3.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8861

85226

1.34

19.04

4.9

4.2

mmol/l

2.9

11.62

8346

79901

(4146454)

135

579

2.35

19.00

2.9

2.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

8436

80609

1.29

18.85

4.1

3.4

mmol/l

1.3

1.2

44.69

7960

75500

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8769

84250

1.33

18.68

4.5

3.9

mmol/l

4.8

4.9

32.56

8303

79456

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2498

21101

1.24

18.62

2.0

u/l

145.5

142.8

0.08

2355

19845

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4138

36941

1.20

17.61

7.0

5.6

mmol/l

1.2

3.40

3499

31280

(3050129) First trimester maternal screen panel - Serum or Plasma

806

5882

1.40

17.36

1.5

1.4

—

(3012544) pH of Venous blood

695

4942

1.44

17.32

5.1

3.6

7.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

163

786

2.09

17.27

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

674

4776

1.44

17.12

5.1

3.6

kpa

5.9

5.8

0.10

657

4631

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8479

81298

1.28

16.87

4.5

3.9

mmol/l

6.0

5.7

65.14

7943

75755

(3019150) Specific gravity of Urine by Refractometry

2131

17893

1.24

16.45

4.5

3.6

kg/l

1.0

1.71

354

2710

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1186

9270

1.32

16.35

3.0

2.3

22.4

23.2

1.33

1027

7998

(3008152) Bicarbonate [Moles/volume] in Arterial blood

496

3341

1.51

16.29

5.6

6.6

mmol/l

24.5

24.6

0.49

452

3091

(3016502) Oxygen saturation in Arterial blood

740

5383

1.40

16.22

6.0

7.3

96.3

96.2

0.27

705

5167

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

219

1201

1.84

16.01

1.1

iu/ml

72.3

9182.6

0.64

293

(3013707) Erythrocyte sedimentation rate by Westergren method

6836

64192

1.20

15.91

4.4

3.9

mm/h

12.3

10.7

20.59

6438

60220

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

232

1298

1.81

15.89

3.9

2.2

nmol/l

0.9

0.8

0.70

187

1107

(40768446) Kidney Pathology biopsy report

212

3.08

15.72

1.8

1.6

—

(3002032) Base excess in Venous blood by calculation

663

4759

1.42

15.68

5.5

3.6

mmol/l

1.7

2.0

1.05

548

3923

(3000850) Epithelial cells [#/volume] in Urine

1808

14980

1.25

15.63

2.8

2.3

e6/l

8.1

0.01

1567

12965

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2267

19259

1.23

15.55

2.4

2.2

mg/l

3.0

2.7

5.07

1989

16560

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

586

4119

1.45

15.54

2.2

2.1

ug/l

4.9

5.9

0.91

516

3564

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1289

10263

1.29

15.45

2.9

2.2

g/l

2.5

0.07

1193

9508

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.51

15.13

5.3

5.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

814

6086

1.37

15.10

3.0

2.3

ml/min/173m2

68.1

73.5

3.00

301

2273

(3020630) Protein [Mass/volume] in Serum or Plasma

654

4724

1.41

14.92

2.5

g/l

66.4

67.2

1.55

603

4341

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

282

1700

1.68

14.86

1.5

1.3

u/ml

15.6

20.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2495

21488

1.21

14.83

1.7

1.6

mmol/l

1.4

1.3

4.86

2092

18457

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3712

33183

1.19

14.68

6.1

4.9

mmol/l

1.2

2.23

3419

30223

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

264

1573

1.70

14.55

1.6

1.3

u/ml

127.4

110.8

0.66

363

(3002173) Hemoglobin [Mass/volume] in Arterial blood

699

5131

1.39

14.51

6.4

7.5

g/l

119.2

119.9

0.40

661

4934

(3022948) Iron [Moles/volume] in Serum or Plasma

1402

11366

1.27

14.49

2.9

2.2

umol/l

13.4

14.1

3.57

1302

10545

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1061

8316

1.31

14.25

2.0

2.1

nmol/l

352.6

376.2

3.70

969

7659

(3027273) Bicarbonate [Moles/volume] in Venous blood

367

2390

1.56

14.12

3.9

2.9

mmol/l

25.2

25.5

0.70

356

2315

(3024354) Oxygen [Partial pressure] in Venous blood

543

3837

1.44

14.00

4.1

3.0

kpa

4.7

4.6

0.12

531

3709

(3042733) HLA Ab [Presence] in Serum

175

3.15

13.91

5.1

—

(3026782) Osmolality of Urine

1643

13633

1.25

13.85

2.9

2.5

mosm/kgh2o

526.6

513.8

1.38

1433

11542

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

866

6623

1.34

13.83

2.7

2.1

u/l

8123.3

5514.9

1.45

395

2645

(3015235) Bicarbonate [Moles/volume] in Capillary blood

222

1282

1.75

13.72

2.9

2.7

mmol/l

24.3

24.8

0.89

200

1126

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

279

1714

1.65

13.70

1.6

1.3

—

(3019060) Gas panel - Arterial blood

490

3417

1.46

13.57

3.8

4.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

259

2.71

13.54

42.3

31.9

ug/l

7.3

0.00

235

(40761511) CBC panel - Blood by Automated count

9362

91388

1.37

13.39

13.3

10.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

135

671

2.03

13.29

3.9

3.4

mu/l

29.0

28.6

0.04

128

644

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

117

552

2.13

13.23

1.4

nmol/l

1.6

1.5

0.70

108

502

(3027801) Oxygen [Partial pressure] in Arterial blood

816

6232

1.34

13.14

6.2

6.8

kpa

13.0

13.4

1.32

780

5966

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

815

6235

1.33

12.97

6.2

6.8

kpa

5.0

5.1

1.82

781

5973

(46235355) HIV 1 and 2 tests - Meaningful Use set

2564

22370

1.20

12.97

2.0

1.9

—

(3022313) Gas panel - Capillary blood

358

2365

1.53

12.94

3.4

3.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4817

44316

1.17

12.78

3.3

2.9

ug/l

81.7

78.1

0.63

4552

41860

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

278

1739

1.62

12.73

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

888

6904

1.31

12.61

2.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

717

5427

1.35

12.26

4.6

3.3

ng/l

91.2

77.1

3.12

617

4742

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

200

1159

1.74

12.26

1.4

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

573

4191

1.39

12.17

2.5

ng/l

143.1

123.1

0.59

507

3794

(3004119) Hemoglobin [Mass/volume] in Venous blood

444

3106

1.45

12.12

4.2

3.1

g/l

126.2

129.4

2.42

432

3031

(3003396) Base excess in Arterial blood by calculation

809

6244

1.32

12.10

6.2

6.8

mmol/l

0.9

1.0

0.30

631

4879

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

261

1629

1.62

12.08

1.3

1.2

u/ml

275.5

273.1

0.05

195

1077

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

10.85

11.95

4.2

2.7

—

(3000991) Gas panel - Venous blood

613

4560

1.37

11.73

8.9

7.8

—

(3023520) Reticulocytes [#/volume] in Blood

595

4421

1.37

11.48

2.8

2.5

e9/l

75.9

71.4

1.92

450

3199

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8911

86626

1.26

11.42

13.2

11.1

mg/l

18.4

19.2

1.67

7352

66421

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

209

1252

1.68

11.39

1.6

mmol/l

7.9

7.5

1.19

136

768

(3048929) Epstein Barr virus Ab [Presence] in Serum

425

2995

1.44

11.17

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

895

7081

1.29

11.13

6.6

6.5

mmol/l

104.3

104.7

2.04

875

6951

(3002582) Erythrocytes [#/volume] in Urine

2463

21655

1.18

11.10

3.3

2.8

e6/l

31.9

75.4

3.45

1920

16093

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2256

19701

1.19

11.00

2.2

2.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

107

529

2.03

10.78

1.2

1.1

u/ml

38.6

10.7

0.50

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2533

22395

1.18

10.59

1.7

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

325

2202

1.49

10.49

3.9

4.7

1.6

1.7

2.46

302

2048

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

287

1902

1.52

10.30

1.9

2.0

ug/l

1.7

1.8

0.09

261

1700

(3017181) Myelocytes/100 leukocytes in Blood

833

6595

1.29

10.30

4.3

4.0

0.9

0.09

215

1553

(3014111) Lactate [Moles/volume] in Serum or Plasma

637

4865

1.33

10.26

6.9

6.5

mmol/l

1.2

0.31

621

4717

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

340

2335

1.47

10.26

4.2

2.9

0.7

0.81

325

2237

(3027945) Reticulocytes/100 erythrocytes in Blood

790

6217

1.29

10.24

2.6

2.5

1.9

1.8

3.19

699

5523

(3002179) Metamyelocytes/100 leukocytes in Blood

771

6051

1.30

10.20

3.9

0.6

0.7

0.10

155

1133

(3025159) Blasts/100 leukocytes in Blood

767

6029

1.29

10.03

4.3

4.1

0.1

0.4

1.32

169

1224

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

345

2389

1.46

9.99

4.3

2.9

1.2

1.3

1.52

345

2369

(3021440) Promyelocytes/100 leukocytes in Blood

799

6324

1.29

9.90

4.4

4.1

0.1

0.2

0.21

201

1441

(3027923) C peptide [Moles/volume] in Serum or Plasma

348

2.22

9.81

1.8

nmol/l

1.4

1.3

0.44

285

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.98

9.75

7.3

11.7

mmol/l

4.3

4.7

0.46

(3021589) Normoblasts [#/volume] in Blood

4075

37508

1.15

9.69

9.4

8.3

e9/l

0.0

0.03

3471

30722

(3007930) Methemoglobin/Hemoglobin.total in Blood

317

2180

1.47

9.53

3.9

4.8

0.9

0.04

295

2031

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2015

17633

1.18

9.39

1.3

u/ml

10.2

11.2

0.25

873

7358

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1461

12434

1.20

9.33

3.1

3.0

ng/l

395.4

279.4

0.64

878

7484

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

242

1582

1.54

9.29

3.4

2.2

—

(3030467) Casts [#/volume] in Urine by Automated count

2250

19881

1.17

9.29

3.2

2.7

e6/l

0.3

0.48

1762

14487

(1616796) Gas panel - Central venous blood

204

1287

1.60

9.15

3.4

2.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1213

10164

1.22

9.08

1.7

1.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

507

3817

1.35

9.03

2.1

2.2

—

(3000034) Microalbumin [Mass/volume] in Urine

110

589

1.88

8.88

3.3

2.7

mg/l

173.5

28.4

1.99

391

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

193

1212

1.60

8.84

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

232

2.42

8.75

1.3

4.9

mg/l

3830.1

1579.2

0.25

167

(3020891) Body temperature

307

2135

1.45

8.75

5.0

4.3

—

(3024471) HLA-A [Type]

198

2.53

8.60

1.0

—

(3042936) Bacteria identified in Isolate by Culture

1193

10035

1.21

8.57

2.1

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

306

2136

1.45

8.56

3.6

3.0

mmol/l

25.0

24.9

0.30

286

1994

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2598

23328

1.15

8.55

1.3

u/ml

1.4

1.5

0.31

813

6611

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

156

937

1.68

8.53

1.4

mmol/l

11.1

11.0

0.03

154

(3012565) Volume of 24 hour Urine

346

2.12

8.33

2.4

1.8

1785.3

1952.5

0.81

317

(3034770) Mitochondria Ab [Titer] in Serum

338

2417

1.41

8.29

1.3

titre

800.6

880.7

0.13

(3011985) Renin [Units/volume] in Plasma

177

1108

1.61

8.24

1.7

1.6

mu/l

65.1

50.8

0.32

157

1003

(3003694) ABO and Rh group [Type] in Blood

2941

26726

1.14

8.05

1.8

1.6

—

(4034850)

358

2599

1.39

8.05

9.7

7.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1824

16024

1.17

7.96

1.5

nmol/l

21.1

21.5

0.62

1590

13937

(3028626) Oxygen [Partial pressure] in Capillary blood

179

1134

1.59

7.95

2.7

2.4

kpa

8.7

8.6

0.42

166

1056

(3019309) Folate [Moles/volume] in Red Blood Cells

1362

11679

1.19

7.94

1.8

1.7

nmol/l

1222.8

1178.5

1.03

1100

8980

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

397

2941

1.36

7.89

7.4

8.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

491

1.90

7.89

1.7

2.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

164

1024

1.61

7.75

1.5

1.4

pmol/l

438.7

349.7

0.48

137

796

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

904

7471

1.23

7.72

3.4

pmol/l

4.5

0.16

819

6693

(3019225) pH of Specimen

874

7204

1.23

7.65

4.3

3.6

—

(3021901) Oxygen saturation in Capillary blood

151

927

1.64

7.64

2.7

2.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

175

1115

1.58

7.61

1.5

1.4

—

(3024932) HLA-DR beta [Type]

193

2.44

7.54

1.1

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

236

1609

1.48

7.51

3.7

4.0

mmol/l

3.8

1.57

225

1517

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

401

3001

1.35

7.49

2.2

1.9

g/l

0.2

0.14

381

2850

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

410

3086

1.34

7.37

2.1

1.8

g/l

1.2

1.98

395

2936

(3037522) Nuclear Ab [Titer] in Serum

1604

14031

1.17

7.35

1.4

titre

534.5

579.9

0.44

340

2989

(40767503) Oxygen content in Capillary blood by calculation

185

1205

1.55

7.32

2.4

2.2

16.7

16.6

0.13

582

(3010421) pH of Blood

232

1591

1.47

7.18

3.2

3.0

7.4

0.60

194

1319

(3008116) Ketones [Moles/volume] in Urine by Test strip

122

2.79

7.14

1.4

—

(3047181) Lactate [Moles/volume] in Blood

271

1917

1.43

7.12

4.0

5.2

mmol/l

1.2

1.3

1.33

234

1691

(3007461) Platelets [#/volume] in Blood

9803

97063

1.46

6.97

20.4

16.7

e9/l

267.1

268.1

0.78

9665

95030

(3012501) Base excess in Blood by calculation

200

1344

1.50

6.87

3.0

3.1

mmol/l

2.3

2.5

0.55

118

901

(3013290) Carbon dioxide [Partial pressure] in Blood

200

1344

1.50

6.87

3.0

3.1

kpa

5.0

0.54

194

1319

(3027315) Oxygen [Partial pressure] in Blood

202

1362

1.49

6.83

3.0

3.2

kpa

9.0

8.8

0.75

196

1337

(36304419) Bacteria [Presence] in Urine

2205

19849

1.14

6.76

3.1

2.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

213

1459

1.47

6.67

1.1

125.1

120.5

1.29

192

1322

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

724

5940

1.24

6.64

3.8

3.2

mmol/l

1.2

0.50

650

5186

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

501

1.80

6.54

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

112

664

1.69

6.54

1.2

1.1

ratio

1.0

1.1

1.20

239

(3010813) Leukocytes [#/volume] in Blood

9808

97164

1.44

6.50

20.5

16.7

e9/l

6.9

6.6

48.27

9651

94926

(3035941) MCH [Entitic mass]

9805

97130

1.44

6.48

20.3

16.6

29.9

30.1

22.57

9721

96117

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2055

18461

1.14

6.47

1.3

iu/ml

30.2

33.2

0.28

662

5891

(3000963) Hemoglobin [Mass/volume] in Blood

9809

97179

1.44

6.46

20.5

16.7

g/l

132.7

133.0

1.75

9725

96171

(3018095) Leukocytes [#/volume] in Urine

2974

27354

1.12

6.42

3.9

3.3

e6/l

98.3

85.0

0.45

2113

17854

(3007566) Smooth muscle Ab [Titer] in Serum

326

2424

1.36

6.40

1.2

1.3

titre

137.6

149.0

0.07

240

(3037756) Immunofixation for Serum or Plasma

155

1002

1.56

6.40

1.8

1.7

—

(3026361) Erythrocytes [#/volume] in Blood

9806

97150

1.43

6.39

20.4

16.6

e12/l

4.5

4.4

4.76

9647

94965

(3024731) MCV [Entitic volume]

9805

97141

1.43

6.36

20.3

16.6

90.0

90.6

32.27

9721

96129

(40760892) CBC W Ordered Manual Differential panel - Blood

2283

20681

1.13

6.30

4.6

4.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

396

3041

1.31

6.26

1.5

u/ml

5.8

9.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1035

8853

1.19

6.18

1.2

iu/ml

158.5

152.5

0.19

437

3520

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1062

9107

1.19

6.16

2.3

2.5

umol/l

6.8

6.4

0.27

898

7647

(3022621) pH of Urine by Test strip

662

5430

1.23

6.10

3.0

2.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

434

3387

1.29

6.09

7.6

8.5

94.3

94.2

0.15

434

3374

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3264

30254

1.12

6.08

2.0

1.8

pmol/l

99.6

100.6

0.50

1721

15171

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

220

1550

1.43

5.98

3.4

3.2

mg/l

30.9

33.9

0.26

175

1249

(3036525) Urea [Moles/time] in 24 hour Urine

6.26

5.95

1.8

2.2

—

(3045424) Erythrocytes [Presence] in Urine

206

1437

1.44

5.92

1.6

1.5

—

(40761535) Cells panel - Urine sediment

688

5687

1.23

5.90

4.5

3.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

214

1505

1.43

5.88

3.2

ratio

1.5

2.0

0.29

145

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

796

6686

1.21

5.81

1.5

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

219

1551

1.42

5.80

3.4

3.2

mg/l

34.3

77.2

0.61

175

1249

(3039000) Anion gap in Blood

184

1263

1.47

5.76

4.7

6.5

mmol/l

11.4

11.0

0.75

162

1126

(3018572) Chloride [Moles/volume] in Blood

184

1264

1.46

5.74

4.7

6.5

mmol/l

105.2

105.4

0.14

162

1127

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

321

2425

1.33

5.72

1.6

titre

575.3

280.0

0.53

111

(4306422)

218

1547

1.42

5.72

1.2

—

(3018418) pH of Serum or Plasma

2433

22265

1.12

5.59

4.7

3.6

7.4

0.31

523

4160

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

480

3837

1.26

5.59

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

2162

19651

1.13

5.57

3.7

3.4

100.5

98.0

5.06

2065

19044

(1761482) Bacteria [#/volume] in Urine by Culture

201

1416

1.43

5.50

3.6

3.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

209

1483

1.42

5.50

1.4

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

172

1179

1.47

5.45

3.6

3.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

254

1867

1.37

5.43

1.7

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

121

770

1.58

5.42

1.4

1.2

u/l

47.8

28.2

0.81

108

674

(3017143) Hepatitis C virus Ab [Presence] in Serum

1363

12040

1.15

5.41

1.7

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

210

1497

1.41

5.39

3.3

3.5

u/ml

0.4

0.12

127

833

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

552

0.36

5.36

12.7

11.8

nmol/l

653.5

844.7

2.66

532

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

351

1.86

5.29

1.2

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

332

2551

1.31

5.28

7.2

4.1

mmol/l

23.9

24.4

2.40

287

2304

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

622

5149

1.22

5.28

1.5

—

(3000330) Specific gravity of Urine by Test strip

440

3506

1.27

5.28

3.1

2.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

360

1.84

5.21

1.2

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

796

6758

1.19

5.19

1.6

1.7

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.13

5.18

2.6

3.6

mmol/l

0.7

0.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

116

743

1.57

5.08

1.8

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

575

1.64

4.98

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

410

1.76

4.96

1.6

1.4

nmol/l

135.6

132.2

0.29

410

(3020491) Glucose [Moles/volume] in Blood

100

623

1.61

4.93

1.5

1.6

mmol/l

6.1

6.2

0.12

468

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

524

1.67

4.90

1.8

1.7

101.4

101.0

0.03

469

(3030981) Hyaline casts [#/volume] in Urine by Automated count

427

3424

1.26

4.89

2.9

2.3

e6/l

0.2

0.3

0.90

407

3275

(3011397) Hemoglobin [Presence] in Urine by Test strip

2142

19599

1.12

4.86

4.3

3.4

—

(1761868) Lipid panel - Serum or Plasma

3593

33775

1.10

4.82

2.7

2.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

609

5082

1.21

4.80

1.7

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

147

1008

1.47

4.71

2.7

2.9

1.7

1.3

0.70

110

799

(3006315) Basophils [#/volume] in Blood

4478

42568

1.09

4.67

5.9

5.8

e9/l

0.0

0.60

3968

37307

(3022689) Creatine [Moles/volume] in Urine

204

2.06

4.67

1.5

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

449

1.70

4.62

3.5

3.1

—

(3045414) Leukocytes [Presence] in Urine

487

3990

1.23

4.61

1.9

1.8

—

(3017732) Neutrophils [#/volume] in Blood

757

6472

1.18

4.58

2.3

2.5

e9/l

4.3

4.0

1.26

615

5338

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

372

2959

1.27

4.58

1.9

2.0

iu/l

27.4

16.0

0.20

143

1209

(3006184) Hemoglobin [Mass/volume] in Capillary blood

190

1378

1.39

4.49

2.4

2.0

g/l

130.0

130.5

0.10

151

964

(3001186) Copper [Moles/volume] in Serum or Plasma

230

1.96

4.38

1.5

1.4

umol/l

17.9

17.8

0.05

203

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

356

2839

1.26

4.31

1.9

2.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

328

2592

1.27

4.29

1.8

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

303

1.82

4.28

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

1155

1.41

4.25

2.5

2.6

—

(3001604) Monocytes [#/volume] in Blood

4453

42439

1.09

4.23

5.9

5.8

e9/l

0.5

1.53

3957

37252

(3028026) IgM [Mass/volume] in Serum or Plasma

583

4912

1.20

4.19

1.8

g/l

1.3

0.04

534

4520

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

228

1.93

4.13

2.0

1.9

ug/min

25.5

91.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

171

1238

1.39

4.12

1.2

1.3

nmol/l

0.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

148

1045

1.42

4.11

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

519

1.60

4.10

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

434

3560

1.23

4.10

5.9

6.2

mmol/l

24.5

24.8

1.51

428

3533

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

527

1.60

4.10

1.6

1.9

u/field

1.8

2.3

0.50

246

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

158

1133

1.40

4.03

1.1

1.2

—

(3003181) Sodium [Moles/volume] in Urine

140

985

1.43

3.98

1.3

1.4

mmol/l

62.8

63.7

0.09

110

769

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

221

1676

1.33

3.96

1.2

1.3

—

(3013115) Eosinophils [#/volume] in Blood

4619

44173

1.08

3.94

6.0

e9/l

0.2

7.69

4184

39355

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

170

1241

1.38

3.91

1.1

1.3

nmol/l

0.5

1.8

0.73

164

1204

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

448

1.63

3.91

1.2

28.3

65.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

472

1.61

3.88

1.1

1.0

88.6

93.3

0.82

378

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

762

6613

1.16

3.87

2.2

g/l

0.2

0.43

722

6230

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

191

1424

1.35

3.86

6.6

5.1

iu/ml

1292.2

678.2

0.52

176

(3019198) Lymphocytes [#/volume] in Blood

4589

43909

1.08

3.82

5.9

5.7

e9/l

2.0

0.85

4154

39286

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

339

1.72

3.74

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

104

700

1.49

3.74

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

540

1.56

3.73

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.63

3.65

6.1

5.4

umol/l

355.8

429.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

733

6373

1.16

3.65

2.7

g/l

10.5

10.3

0.49

671

5846

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

888

10031

0.87

3.58

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

206

1572

1.32

3.58

1.3

1.2

u/ml

4.6

3.8

0.34

643

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

267

2109

1.27

3.57

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

209

1602

1.31

3.52

1.3

1.2

u/ml

3.4

2.7

0.27

539

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

204

1560

1.31

3.50

1.4

mmol/l

6.6

6.9

1.11

159

1153

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.00

3.49

6.7

2.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

184

1387

1.33

3.49

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

147

1070

1.38

3.49

1.1

93.3

94.1

0.15

136

1006

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

463

1.58

3.46

1.6

nmol/l

2.5

14.2

0.52

385

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1060

9492

1.13

3.45

4.6

3.9

32.1

33.0

2.19

810

6697

(3023183) Ammonium ion [Moles/volume] in Plasma

148

1085

1.37

3.38

3.1

2.7

umol/l

34.9

32.8

0.41

132

945

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

1078

1.37

3.35

3.0

2.4

u/ml

139.8

2382.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

986

8808

1.13

3.34

6.5

5.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6926

67533

1.08

3.34

3.7

3.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

397

3304

1.21

3.32

2.2

2.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

128

920

1.40

3.30

1.3

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

230

1807

1.28

3.25

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

201

1554

1.30

3.22

1.1

—

(3006504) Eosinophils/100 leukocytes in Blood

4161

39843

1.08

3.21

5.9

2.9

2.8

2.44

3869

37232

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3976

38010

1.08

3.21

2.5

2.3

nmol/l

75.4

2410.0

0.50

3678

35151

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

145

1070

1.36

3.20

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

269

2163

1.25

3.14

2.3

2.1

g/l

7.4

7.3

0.46

196

1662

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

142

1048

1.36

3.14

1.3

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

4179

40048

1.07

3.13

6.2

6.1

7.9

8.1

4.33

3919

37716

(4024509)

110

778

1.42

3.13

1.6

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

228

1801

1.27

3.10

1.7

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

2160

1.25

3.08

2.3

2.1

g/l

3.6

3.7

0.21

183

1577

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

268

2160

1.25

3.08

2.3

2.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.68

3.05

1.0

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

197

1532

1.29

3.04

1.1

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

5.84

3.02

8.1

3.3

g/l

2.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

105

742

1.42

3.01

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

385

1.59

3.00

1.1

93.1

95.4

0.30

151

(3040151) Glucose [Moles/volume] in Capillary blood

668

1.44

3.00

2.3

6.7

mmol/l

8.0

7.4

0.42

535

(3007164) IgA [Mass/volume] in Serum or Plasma

2096

19584

1.09

2.99

1.4

g/l

2.2

2.1

1.85

1320

12183

(3004451) EKG impression Narrative

219

1.78

2.96

1.2

—

(40768797) Stomach Pathology biopsy report

1311

11991

1.11

2.95

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

169

1.90

2.94

1.4

1.3

mu/l

37.7

75.0

1.35

130

(40761539) Cells [Type] in Urine sediment by Light microscopy

155

1.94

2.93

1.4

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

413

3495

1.19

2.93

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

242

1.74

2.92

1.4

1.1

—

(3034614) HLA Ag [Interpretation]

4.71

2.91

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

144

1079

1.34

2.91

1.1

g/l

1.5

0.35

131

975

(44806420)

108

2.13

2.89

2.3

2.2

—

(3020650) Glucose [Presence] in Urine

228

1.76

2.89

1.3

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

327

1.62

2.88

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

140

1047

1.34

2.87

1.3

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

610

1.45

2.83

2.6

2.8

60.5

55.6

1.04

394

(3037556) Urate [Mass/volume] in Serum or Plasma

172

1.86

2.80

1.3

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

608

6913

0.87

2.75

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

152

1.91

2.74

1.0

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

7595

74524

1.08

2.72

15.7

13.5

13.6

13.5

0.59

7458

73119

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

254

2067

1.23

2.72

2.4

2.2

g/l

3.0

0.01

190

1627

(3022096) Basophils/100 leukocytes in Blood

4009

38507

1.07

2.69

6.0

5.9

0.7

1.54

3730

35995

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

4.21

2.67

5.5

4.3

mmol/l

0.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

494

1.48

2.67

1.1

miu/ml

1718.9

1508.0

0.86

494

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.75

2.67

1.6

1.1

—

(3047189) Immunofixation for 24 hour Urine

212

1.75

2.65

1.5

1.9

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

661

1.41

2.63

1.1

mg/l

291.9

304.7

0.94

581

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

375

1.55

2.62

1.1

97.1

98.3

0.08

151

(3002030) Lymphocytes/100 leukocytes in Blood

4306

41490

1.07

2.60

5.9

29.3

29.7

2.07

4002

38921

(3016650) Hepatitis A virus Ab [Presence] in Serum

177

1389

1.28

2.60

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

134

1014

1.33

2.58

1.3

1.5

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

100

2.10

2.58

2.1

1.8

mmol/l

1.2

0.51

(3006598) pH of Arterial cord blood

4.00

2.56

1.1

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

134

1016

1.32

2.55

1.3

1.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

7.14

2.55

1.2

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

134

1018

1.32

2.52

1.3

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

395

1.52

2.52

1.5

1.7

u/field

2.8

2.2

0.12

276

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

372

3167

1.18

2.51

1.1

u/ml

7.3

5.2

0.15

492

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.11

2.48

22.2

7.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

454

1.48

2.46

1.2

u/l

23.2

20.4

0.18

362

(3015171) Extractable nuclear Ab [Units/volume] in Serum

509

4451

1.15

2.44

1.3

u/ml

0.5

1.1

1.44

366

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

135

1032

1.31

2.44

1.3

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

456

1.47

2.41

1.1

1.2

u/l

82.6

78.8

0.15

376

(3018010) Neutrophils/100 leukocytes in Blood

4246

40966

1.06

2.40

5.8

5.7

56.8

56.2

2.89

3966

38531

(3014148) Varicella zoster virus Ab [Titer] in Serum

187

1494

1.26

2.40

1.2

—

(42870588) Differential panel, method unspecified - Blood

2901

27652

1.07

2.40

5.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

182

1.76

2.38

1.2

pmol/l

479.4

350.0

0.68

133

(3024522) Salmonella sp identified in Specimen by Organism specific culture

134

1028

1.31

2.37

1.3

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

574

1.41

2.37

1.3

1.4

ug/l

6.5

0.00

517

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

175

2190

0.80

2.37

3.8

3.6

u/ml

33.9

33.1

0.03

168

2117

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

170

1347

1.27

2.35

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

221

1.68

2.33

2.1

2.3

—

(3017704) Immunofixation for Urine

244

1.64

2.33

1.7

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5055

49085

1.06

2.27

8.3

8.9

e9/l

4.1

3.9

9.16

4522

43180

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

389

1.49

2.26

1.1

116.0

117.9

0.15

347

(3022670) pH of Venous cord blood

3.89

2.25

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

2006

1.21

2.23

2.0

2.1

g/l

10.1

0.03

204

1710

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

530

0.60

2.20

1.5

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

551

4885

1.14

2.19

1.5

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

106

1396

0.76

2.18

1.0

u/ml

0.5

0.3

0.18

280

(3010726) Horse dander IgE Ab [Units/volume] in Serum

158

1977

0.80

2.17

1.1

u/ml

2.0

1.5

0.14

473

(3034092) Cytoplasmic Ig cells/100 cells in Blood

122

1.89

2.15

5.4

7.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

650

7234

0.89

2.15

3.2

3.7

ug/l

17.2

23.0

0.25

469

5427

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

166

1.75

2.14

1.7

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

612

1.38

2.13

1.6

41.0

38.2

0.24

339

(21494755) Public health laboratory ask at order entry panel

1044

11328

0.91

2.11

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

223

1846

1.21

2.10

2.2

g/l

0.5

0.6

0.16

198

1619

(3027456) Digoxin [Moles/volume] in Serum or Plasma

588

1.38

2.10

3.7

3.2

nmol/l

0.8

0.50

451

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.70

2.10

1.3

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

1119

1.27

2.09

1.3

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

101

761

1.33

2.07

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

547

4869

1.13

2.06

1.5

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

235

1963

1.20

2.03

1.2

1.3

e6/l

26.5

37.7

0.19

191

1505

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

235

1965

1.20

2.01

1.3

1.4

e6/l

406.6

2947.0

0.75

203

1590

(3034988) Calcium [Moles/volume] in Capillary blood

111

1.89

2.00

2.8

1.9

mmol/l

1.2

0.50

103

(3033705) Calcium.ionized [Moles/volume] in Venous blood

543

1.38

1.99

2.9

2.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

549

4902

1.13

1.98

1.5

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

451

0.60

1.96

1.6

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

101

769

1.32

1.95

1.2

—

57.2

—

(3019174) dRVVT (LA screen)

105

1.91

1.95

1.2

—

(3024263) Appearance of Synovial fluid

321

1.50

1.94

1.9

2.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2819

27004

1.06

1.94

3.0

3.3

mmol/l

2.3

2.4

2.26

2518

23955

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.55

1.94

1.0

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

187

1.66

1.93

1.0

ug/l

63.3

74.2

1.18

158

(3023430) Cat dander IgE Ab [Units/volume] in Serum

129

1626

0.79

1.92

1.1

u/ml

3.8

4.2

0.09

653

(40768441) Liver Pathology biopsy report

650

1.34

1.91

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

754

1.32

1.91

1.2

u/ml

52.2

44.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

548

4906

1.12

1.90

1.5

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

106

1.89

1.90

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

235

1.58

1.89

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

235

1.58

1.89

1.5

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

234

1970

1.19

1.88

1.2

mmol/l

3.8

3.6

1.68

217

1847

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.31

1.87

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

144

1.74

1.84

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.17

1.82

1.0

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

694

0.69

1.82

1.8

2.1

48.6

45.0

—

115

(3008898) HLA-B27 [Presence]

482

4299

1.13

1.80

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

140

1728

0.81

1.76

1.1

u/ml

2.9

4.8

0.87

639

(3024928) Oxygen saturation in Venous blood

141

1138

1.24

1.75

5.2

3.4

—

(3045716) Anion gap in Serum or Plasma

248

1.53

1.75

4.0

2.5

mmol/l

9.2

0.04

179

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1278

11968

1.08

1.74

2.8

2.4

e6/l

1.2

1.5

0.44

779

6453

(3052851) Hemolysis interference index of Serum or Plasma

261

2237

1.17

1.73

2.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

524

1.36

1.72

1.6

1.7

120.0

126.7

0.31

491

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

456

1.38

1.72

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

411

3642

1.13

1.72

2.1

u/l

39.5

39.8

0.12

372

3345

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

856

1.28

1.71

1.3

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.13

1.71

6.2

6.6

—

(4268621)

135

1088

1.24

1.71

2.4

2.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.91

1.69

25.2

7.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

582

5269

1.11

1.69

1.1

titre

104.4

198.0

—

128

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

544

1.34

1.67

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

727

1.30

1.67

1.2

u/ml

2.4

4.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

383

1.41

1.66

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

284

1.48

1.66

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

284

1.48

1.66

1.2

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

180

1.61

1.65

1.1

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

772

1.29

1.65

1.7

91.1

90.5

0.60

759

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

200

1684

1.19

1.65

2.1

g/l

0.0

1.70

188

1535

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

142

1.69

1.64

1.4

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

120

961

1.25

1.62

1.2

u/l

56.7

57.2

0.04

650

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

166

1.63

1.61

1.1

1.3

mg/l

0.5

59.6

0.99

122

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

201

1699

1.19

1.60

1.4

—

(4133840)

190

1.58

1.59

1.3

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

550

1.33

1.57

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

100

787

1.27

1.57

1.2

1.3

titre

—

(4281824)

104

1303

0.80

1.54

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

281

1.46

1.53

20.6

29.2

ug/l

112.4

110.9

0.04

231

(3006922) Hepatitis E virus Ab [Presence] in Serum

605

1.31

1.53

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

693

7529

0.91

1.50

1.8

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.16

1.50

2.0

1.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.16

1.50

1.1

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6131

60200

1.05

1.50

3.1

2.8

u/l

41.8

36.6

5.15

5819

57068

(3036603) Volume of Urine

521

1.33

1.48

2.0

1.6

2186.9

1963.9

0.57

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

300

1.44

1.48

1.5

2.2

ug/l

1.2

0.02

283

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

218

1.52

1.48

1.5

1.6

ug/l

0.4

0.10

153

(3044927) Protein electrophoresis panel - Urine

505

1.33

1.46

1.1

1.2

—

(3011648) Oxygen content in Venous blood

445

1.35

1.46

3.4

2.2

11.4

10.9

0.55

445

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

473

1.33

1.42

1.2

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

246

2138

1.15

1.42

1.3

1.2

u/ml

29.6

8.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

141

1.63

1.41

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

263

0.57

1.39

2.9

3.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

563

0.71

1.38

2.5

2.8

e6/l

844.6

841.5

0.01

254

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.94

1.38

1.5

2.9

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.61

1.36

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

455

4122

1.11

1.36

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.94

1.36

4.6

3.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

989

10538

0.93

1.34

1.6

1.4

1.3

0.50

876

9445

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

120

1.67

1.33

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.14

1.33

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

1023

0.79

1.33

1.0

—

(40768793) Breast Pathology biopsy report

274

3103

0.88

1.32

1.2

1.3

—

(3016038) Potassium [Moles/volume] in Urine

385

1.35

1.30

1.2

mmol/l

27.6

34.1

1.79

332

(3022145) Colonoscopy Study observation

999

9383

1.07

1.30

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

411

1.34

1.30

1.2

g/l

0.3

0.00

332

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

317

1.39

1.30

1.0

1.1

ng/l

368.6

560.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

282

0.60

1.29

1.5

1.4

—

(3025941) Bacteria identified in Stool by Culture

607

5593

1.09

1.29

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

145

1.59

1.28

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

151

1275

1.19

1.28

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

310

1.39

1.27

2.0

2.4

au/ml

151.0

145.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

230

0.56

1.26

2.5

1.9

umol/l

17.2

16.5

0.10

230

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

255

2245

1.14

1.26

1.3

mg/l

457.6

479.0

0.24

247

2134

(3048689) Calprotectin [Mass/mass] in Stool

1374

13056

1.06

1.26

2.5

2.3

ug/g

115.2

103.1

0.70

1106

10161

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.82

1.25

1.1

mmol/l

7.9

8.1

0.26

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

115

1.65

1.24

2.9

2.3

mmol/l

8.3

6.8

0.73

(3044242) Glucose [Moles/volume] in Arterial blood

236

1.44

1.24

2.0

1.9

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.86

1.23

1.0

1.1

—

(3000012) Reticulocyte production index

312

1.38

1.23

1.5

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

107

878

1.22

1.23

2.1

1.9

mg/l

28.1

25.3

0.20

241

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.23

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

355

1.35

1.23

1.2

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

111

915

1.22

2.2

2.0

u/ml

10.6

1377.6

0.68

101

829

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

364

1.35

1.22

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1279

12140

1.06

1.22

1.5

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.04

1.21

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

637

1.26

1.21

2.8

2.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

283

2517

1.13

1.20

1.4

1.5

nmol/l

0.6

0.5

0.28

227

1962

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

665

1.25

1.19

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

272

1.40

1.19

2.6

3.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

720

1.24

1.18

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

436

1.31

1.18

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

206

2354

0.87

1.17

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

319

2867

1.12

1.15

1.7

1.6

iu/ml

0.1

5.9

0.51

573

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

221

1942

1.14

1.15

1.4

1.5

iu/ml

31.0

16.0

—

(21494434) Karyotype in Bone marrow

439

1.30

1.13

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

344

1.34

1.12

1.6

1.5

9.3

3.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

597

0.75

1.12

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1489

14235

1.05

1.11

2.0

—

(44813793)

798

1.22

1.11

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

159

1.51

1.11

1.4

ng/l

94.8

80.3

0.47

159

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

202

2301

0.88

1.11

3.3

3.4

u/ml

627.3

473.5

0.18

171

1937

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

276

1.38

1.11

3.1

3.0

umol/l

27.6

27.8

0.04

210

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

117

982

1.19

1.10

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.38

1.09

1.2

1.0

u/field

0.8

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

1.08

1.1

—

(4211845)

460

1.28

1.08

3.3

3.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

278

1.37

1.07

2.5

2.7

—

(3044290) Cell count panel - Cerebral spinal fluid

212

1870

1.14

1.06

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

179

1562

1.15

1.05

1.5

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

261

2335

1.12

1.04

2.2

2.1

mg/l

10.8

10.4

0.37

244

2177

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

536

5778

0.92

1.04

1.0

1.1

—

(3003338) MCHC [Mass/volume]

7560

76361

0.96

1.04

17.0

14.1

g/l

331.6

331.4

1.58

7516

75862

(3026389) Candida sp identified in Specimen by Organism specific culture

175

1529

1.15

1.02

1.5

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.92

1.02

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

179

1568

1.14

1.01

3.9

3.2

mg/l

22.0

23.5

0.23

116

932

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

620

0.77

1.01

2.3

2.6

e9/l

0.2

0.05

523

(3003888) Timothy IgE Ab [Units/volume] in Serum

184

2091

0.88

1.00

1.1

u/ml

2.5

4.8

3.12

1042

(3013637) Mi-2 Ab [Presence] in Serum

197

1.42

0.99

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

197

1.42

0.99

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

197

1.42

0.99

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

197

1.42

0.99

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1091

0.83

0.98

5.0

5.6

umol/l

370.6

381.7

0.31

936

(4010399)

547

5874

0.93

0.98

1.4

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

2.17

0.98

1.2

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

611

1.23

0.98

1.3

1.5

e6/l

9055.9

55843.7

1.85

421

(3028679) Herpes simplex virus Ab [Presence] in Serum

593

1.23

0.97

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

436

4021

1.09

0.97

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

173

1969

0.88

0.97

1.1

u/ml

2.1

1.0

0.35

785

(3008295) Osmolality of Serum or Plasma

684

1.22

0.97

1.3

1.6

mosm/kgh2o

281.1

278.8

0.45

540

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.95

0.97

7.3

3.2

—

(36660697) Celiac disease serology panel - Serum

889

8416

1.06

0.96

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

328

1.31

0.95

2.1

1.8

mg/l

8.5

9.7

0.87

268

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

109

1.56

0.93

1.1

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

192

1.41

0.92

5.4

6.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

172

1515

1.14

0.91

1.4

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

372

3420

1.09

0.91

1.5

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

102

864

1.18

0.91

1.7

1.6

51.6

51.2

0.03

517

(3009542) Hematocrit [Volume Fraction] of Blood

8138

82008

0.96

0.90

13.6

12.0

39.3

39.4

0.76

6090

64950

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

393

1.27

0.90

1.2

1.3

—

603.8

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.07

0.89

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

367

1.28

0.89

1.4

pmol/l

14.3

14.0

0.16

307

(3023323) Follitropin [Units/volume] in Serum or Plasma

901

8559

1.06

0.89

1.3

iu/l

26.9

29.2

1.43

814

7461

(1002224) Polysomnography panel

423

3916

1.08

0.88

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.79

0.87

1.2

1.1

u/l

8.8

12.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

161

1.43

0.86

1.0

1.1

umol/24h

0.5

0.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

334

1.29

0.85

2.6

2.9

mg/l

6.8

7.8

0.61

261

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.82

0.85

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

0.85

6.0

4.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

248

2245

1.11

0.85

1.3

u/ml

0.9

3.6

2.18

177

(3047352) Trisomy 18 risk [Likelihood] in Fetus

434

4031

1.08

0.85

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

187

1.39

0.84

2.3

3.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.63

0.84

6.5

5.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.78

0.84

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

209

2323

0.90

0.83

1.1

u/ml

2.6

1.1

0.72

863

(3006270) Folate [Moles/volume] in Blood

643

1.20

0.82

1.2

1.1

nmol/l

382.7

399.8

0.31

596

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

781

1.18

0.82

1.4

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

689

1.19

0.82

1.3

mmol/l

2.3

2.0

0.85

646

(4015189)

146

1.44

0.82

2.0

2.4

—

(3017569) Oxygen content in Arterial blood

214

1.36

0.82

1.9

2.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

310

2847

1.09

0.80

8.6

8.7

mmol/l

24.0

24.3

0.77

284

2693

(3014051) Protein [Presence] in Urine by Test strip

220

1987

1.11

0.80

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

329

1.28

0.80

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1155

11082

1.05

0.79

2.9

2.5

e6/l

5.8

4.7

1.59

651

5605

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

200

0.65

0.79

1.6

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

259

1.31

0.79

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

383

1.25

0.79

1.2

1.3

titre

64.0

49.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

192

1723

1.12

0.79

1.1

u/ml

3.6

2.8

0.23

916

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

437

1.24

0.79

1.4

u/ml

26.2

19.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

207

1.35

0.79

1.4

1.6

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

233

1.33

0.79

1.1

103.0

86.4

—

(3014891) Appearance of Pleural fluid

1.67

0.78

1.4

2.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

106

1.51

0.78

1.1

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

528

1.21

0.78

1.1

nmol/l

0.2

6.8

1.13

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.62

0.78

1.9

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

565

1.20

0.78

1.5

1.6

u/l

11.9

4.9

1.47

275

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

229

2520

0.91

0.77

1.5

1.3

ug/l

3.2

0.07

197

2256

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

145

1282

1.13

0.77

2.6

3.3

u/ml

167.3

552.8

1.00

129

1165

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

278

1.30

0.77

1.9

2.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

621

1.19

0.76

1.0

1.1

u/l

1.0

1.1

1.08

251

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.76

0.0

1.0

—

270.7

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.76

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

725

0.83

0.75

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

209

1.34

0.75

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.57

0.74

2.5

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

101

873

1.16

0.74

1.8

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

303

2796

1.09

0.73

1.3

u/ml

12.9

6.5

0.38

308

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

118

1034

1.14

0.73

1.1

—

25.8

—

(3025577) Chromium [Mass/volume] in Blood

263

1.29

0.72

2.1

ug/l

2.5

3.0

0.32

227

(3004716) Salmonella sp identified in Stool by Organism specific culture

545

5776

0.94

0.72

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

180

1620

1.11

0.72

1.7

e6/l

14336.1

9297.7

0.71

140

1182

(3025315) Body weight

1.61

0.72

4.7

4.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

204

1849

1.11

0.72

2.0

2.1

ug/l

205.1

532.0

1.68

187

1664

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

188

1697

1.11

0.72

1.7

2.1

g/l

38.3

38.7

0.45

168

1488

(4094501)

211

1917

1.10

0.71

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

164

1470

1.12

0.71

1.4

1.6

—

(3006462) Nitrate [Presence] in Urine

417

1.22

0.70

2.9

3.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

521

0.81

0.69

3.5

3.9

—

(3048879) Bone marrow aspiration report

135

1.41

0.68

1.2

2.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

172

1551

1.11

0.68

1.8

2.1

g/l

0.0

0.50

161

1407

(44806071)

144

1.39

0.67

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

120

0.58

0.67

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

307

2848

1.08

0.67

1.3

u/ml

11.6

8.0

0.29

487

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

763

1.15

0.65

1.4

1.3

umol/l

5.0

5.2

0.16

700

(3000492) Spirometry study

811

8467

0.95

0.64

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

242

1.28

0.64

1.6

2.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

690

1.16

0.63

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

713

6813

1.05

0.62

1.3

u/ml

161.7

185.3

0.33

663

6303

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

288

1.25

0.62

1.1

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

297

1.25

0.62

1.2

1.1

u/ml

45.3

54.3

0.40

289

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

172

1562

1.10

0.61

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

208

1.30

0.61

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

609

0.84

0.60

1.7

1.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

5.4

—

3.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

106

1195

0.89

0.60

1.4

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

243

0.74

0.59

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.51

0.58

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.46

0.57

2.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1648

16047

1.03

0.57

2.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

355

1.21

0.57

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

310

1.23

0.56

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

301

1.23

0.56

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

110

981

1.12

0.56

1.3

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.51

0.56

1.6

2.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

635

0.85

0.55

2.1

2.6

e6/l

569.8

510.6

0.41

522

(3015076) Soybean IgE Ab [Units/volume] in Serum

677

0.86

0.55

1.0

u/ml

0.1

0.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

124

0.64

0.54

1.0

1.1

—

(4027681)

701

1.14

0.54

1.4

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.58

0.54

1.2

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.46

0.54

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

552

1.16

0.53

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

160

1.31

0.53

1.5

1.3

42.2

42.5

0.01

100

(3013139) Helicobacter pylori Ag [Presence] in Stool

655

6832

0.96

0.53

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

562

1.16

0.53

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

562

1.16

0.53

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

562

1.16

0.53

1.4

1.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.54

0.53

1.0

—

6.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

115

1035

1.11

0.52

1.1

—

75.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

167

1532

1.09

0.51

1.9

2.1

g/l

0.0

0.00

159

1404

(3042631) Mycobacterium sp identified in Specimen

723

1.14

0.51

2.1

2.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

789

1.13

0.51

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

746

7752

0.96

0.51

3.0

3.2

u/ml

41.0

44.9

0.20

722

7485

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

189

1744

1.09

0.51

2.5

2.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

259

2420

1.07

0.51

1.3

—

(40768806) Pleura Pathology biopsy report

413

0.82

0.51

2.1

1.4

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.46

0.50

1.2

1.3

u/l

24.5

696.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

118

1.36

0.50

1.8

2.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

332

3133

1.06

0.49

1.3

u/ml

22.6

35.0

0.42

222

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2715

26687

1.02

0.49

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

207

1.26

0.49

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

345

0.81

0.48

1.4

1.5

u/l

11.9

11.6

0.14

331

(3028433) Virus identified in Specimen by Culture

262

1.22

0.48

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

549

1.15

0.48

1.4

1.5

u/l

5.7

5.1

0.61

469

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

208

1.25

0.47

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

208

1.25

0.47

1.0

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

442

4213

1.05

0.47

1.1

u/ml

1.2

2.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

176

1628

1.08

0.47

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

532

1.15

0.46

3.6

2.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

420

1.17

0.46

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1092

10611

1.03

0.46

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

174

1.26

0.44

1.1

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

115

1047

1.10

0.44

1.5

1.6

—

(3001729) Color of Synovial fluid

1.37

0.44

1.1

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

376

1.17

0.44

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

245

2302

1.07

0.44

1.4

ug/g

302.6

297.0

0.15

144

1238

(3020874) Milk IgE Ab [Units/volume] in Serum

753

1.12

0.43

1.0

1.1

u/ml

0.3

1.5

1.43

197

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

772

1.11

0.43

1.4

1.2

u/ml

0.6

1.0

0.54

310

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

129

0.70

0.43

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1008

0.90

0.43

1.6

1.4

—

2890.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

205

2191

0.93

0.42

1.2

—

(3015183) Erythrocyte sedimentation rate

593

1.13

0.42

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.65

0.42

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.38

0.42

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.40

0.42

1.0

1.1

—

29.4

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.40

0.42

1.0

1.1

—

20.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.63

0.42

1.3

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

505

4851

1.04

0.41

1.4

1.6

mu/l

272.3

316.2

3.36

441

4310

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

105

957

1.10

0.40

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

306

3223

0.95

0.40

2.1

2.0

—

(3023419) Bacteria identified in Sputum by Culture

752

0.89

0.40

2.5

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

681

1.12

0.40

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.43

0.39

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

106

1.32

0.39

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

196

1.23

0.39

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

551

1.13

0.38

1.1

u/ml

12.6

9.6

0.15

(3021788) Differential panel - Synovial fluid

137

1269

1.08

0.38

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

298

2835

1.05

0.37

1.2

—

(3049717) Cytology report of Urine Cyto stain

159

1483

1.07

0.37

2.1

2.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

781

1.10

0.37

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

403

4200

0.96

0.36

1.8

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

170

1592

1.07

0.36

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

577

0.88

0.36

1.2

—

(3028300) Cannabinoids [Presence] in Urine

406

4229

0.96

0.36

1.8

1.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

516

1.12

0.36

1.8

2.0

ug/l

59.8

23.4

0.42

507

(3027008) Opiates [Presence] in Urine

405

4217

0.96

0.35

1.8

1.9

—

(3045142) Bone marrow Pathology biopsy report

631

1.11

0.35

1.5

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

402

3861

1.04

0.35

1.6

—

(40758292) HTLV I+II Ab panel - Serum

122

0.74

0.35

1.1

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

123

0.73

0.35

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

124

0.73

0.35

1.2

1.0

—

(3042517) Benzodiazepines panel - Urine

134

0.75

0.34

1.8

2.3

—

(3000494) Fungus identified in Specimen by Culture

947

9707

0.97

0.34

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

843

1.09

0.34

1.2

1.1

—

(3034426) Prothrombin time (PT)

339

1.15

0.34

1.2

—

(3016879) Cocaine [Presence] in Urine

370

3853

0.96

0.33

1.9

2.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

109

1.28

0.33

1.2

1.6

ng/l

94.7

64.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.69

0.33

1.0

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

247

1.17

0.32

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

703

1.10

0.31

1.3

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.30

0.31

2.2

u/field

0.9

0.8

0.07

(42529406) Shigella sp [Presence] in Stool by Culture

264

2764

0.95

0.31

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

333

1.14

0.31

1.1

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

411

0.88

0.31

2.5

2.8

47.0

44.3

0.35

156

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

156

1.22

0.31

1.3

1.2

nmol/l

0.4

0.07

102

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

146

1372

1.07

0.30

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

146

1372

1.07

0.30

1.3

—

(3016330) Potassium [Moles/time] in 24 hour Urine

138

1.23

0.30

1.2

—

89.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.29

0.30

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.29

0.30

1.4

1.5

15.9

21.5

0.56

(3014765) Yersinia sp identified in Stool by Organism specific culture

264

2759

0.96

0.29

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

404

3900

1.04

0.29

2.4

2.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

122

1141

1.07

0.29

3.6

4.5

u/ml

112.5

102.4

0.07

358

(3027135) IgG subclass 1 [Mass/volume] in Serum

102

948

1.08

0.29

1.5

1.4

g/l

6.5

6.7

0.19

658

(3024891) Influenza virus A+B Ag [Presence] in Specimen

248

2371

1.05

0.29

1.1

—

(3033799) Differential panel - Peritoneal fluid

176

1.19

0.28

1.5

1.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

112

1.25

0.28

1.1

—

(3011412) CD3 cells [#/volume] in Blood

846

0.92

0.28

2.0

2.5

e9/l

1.4

1.3

0.52

498

(3045788) Cell count panel - Pleural fluid

354

0.88

0.27

1.9

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

183

0.82

0.27

1.9

1.5

u/l

10.5

47.7

1.76

157

(3008536) Aspergillus sp Ab [Presence] in Serum

119

0.76

0.27

1.1

2.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

297

2857

1.04

0.27

1.2

u/l

12.1

13.4

0.89

248

2366

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

673

6897

0.97

0.27

2.3

au/ml

17.6

23.6

0.85

504

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

464

4781

0.97

0.26

1.8

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

692

1.08

0.26

2.8

3.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

433

1.11

0.26

1.5

1.7

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

106

992

1.07

0.26

1.3

1.4

nmol/l

25.8

31.5

1.73

913

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.68

0.26

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

311

3225

0.96

0.26

1.5

1.3

—

(3000285) Sodium [Moles/volume] in Blood

1.23

0.25

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

123

1160

1.06

0.25

1.3

nmol/l

1.2

1.4

0.88

101

948

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.18

0.24

1.0

1.1

umol/24h

1.6

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

101

947

1.07

0.24

1.5

1.4

g/l

3.1

2.9

0.61

656

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

239

2487

0.96

0.24

1.2

1.3

u/ml

50.3

44.8

0.20

269

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

407

1.11

0.24

1.1

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

101

948

1.07

0.24

1.5

1.4

g/l

0.4

0.30

660

(3025130) Human papilloma virus identified in Specimen

241

2506

0.96

0.24

1.6

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.32

0.23

1.2

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.32

0.23

1.8

7.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

285

0.88

0.22

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.27

0.22

1.1

ug/l

1.6

243.5

—

(3010503) CD19 cells [#/volume] in Blood

493

0.91

0.22

2.1

2.7

e9/l

0.1

0.4

1.45

483

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

797

1.07

0.21

1.1

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

153

1461

1.05

0.21

1.5

g/l

0.6

0.68

121

1095

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.6

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.6

—

(4062490)

100

944

1.06

0.21

1.5

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

175

1825

0.96

0.21

1.2

—

(3027944) Amphetamines [Presence] in Urine

405

4159

0.97

0.21

1.8

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

176

1835

0.96

0.21

2.4

2.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.16

0.21

1.0

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.3

—

2639.5

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

12097.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

287

1.12

0.20

3.2

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

366

0.90

0.20

1.9

2.2

umol/l

291.3

144.2

0.55

192

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

364

1.10

0.20

1.4

1.7

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.6

—

2.4

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

209.4

—

(3029075) Extractable nuclear Ab panel - Serum

297

1.11

0.20

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

868

1.06

0.20

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

868

1.06

0.20

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

622

6346

0.98

0.20

1.2

1.3

au/ml

45.0

42.1

0.08

256

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

365

1.10

0.19

1.4

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

365

1.10

0.19

1.4

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

365

1.10

0.19

1.3

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

771

7576

1.02

0.19

2.6

2.3

u/l

40.4

36.4

0.26

644

6448

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.22

0.19

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

870

1.06

0.19

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

464

4538

1.02

0.18

1.3

miu/ml

192.3

235.0

2.20

215

2294

(3003740) Influenza virus B Ag [Presence] in Specimen

175

1817

0.96

0.18

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

862

1.06

0.18

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

128

1.17

0.18

1.1

1.0

—

(40757373) Influenza virus identified in Isolate

132

0.83

0.18

1.7

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

248

0.89

0.18

1.1

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

166

1.14

0.18

1.1

u/ml

0.0

—

106

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

551

1.07

0.18

1.6

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

300

0.90

0.18

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.17

0.17

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

863

1.05

0.17

1.2

1.1

mg/l

201.9

215.5

0.67

752

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

174

0.86

0.17

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

265

2728

0.97

0.17

1.2

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.21

0.17

1.0

u/ml

0.0

0.2

—

(3012441) Differential panel - Pleural fluid

372

0.91

0.17

2.1

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

864

1.05

0.17

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

184

0.87

0.17

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

184

0.87

0.17

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

184

0.87

0.17

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

215

0.88

0.16

1.1

—

(3002256) Pathology report gross observation

1161

11751

0.99

0.16

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

474

0.93

0.16

1.2

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

246

0.89

0.16

2.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

389

1.08

0.16

1.7

1.4

e6/l

180264.0

45877.8

0.53

209

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.16

1.3

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

235

0.89

0.16

1.3

2.2

ug/l

1.5

3.6

1.06

137

(3044007) Cell count panel - Peritoneal fluid

168

1.13

0.15

1.7

2.2

—

(40762365) Oxygen content in Arterial blood by calculation

0.79

0.15

1.3

1.8

ml/dl

14.8

14.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

119

0.84

0.15

1.1

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

176

1818

0.97

0.15

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

150

0.87

0.14

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

537

1.06

0.14

1.3

1.2

u/l

15.8

20.9

0.84

457

(3044941) Cell count panel - Synovial fluid

1033

0.96

0.14

1.5

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

861

1.05

0.14

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

724

1.05

0.14

1.4

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

141

1.13

0.13

2.2

1.8

—

(3051651) Icteric interference index of Serum or Plasma

439

0.93

0.13

3.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

284

0.92

0.13

1.5

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

284

0.92

0.13

1.5

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

725

0.95

0.13

2.1

1.9

—

(40768795) Lymph node Pathology biopsy report

843

1.04

0.13

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

570

5784

0.98

0.13

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

747

1.04

0.12

3.0

2.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

789

7800

1.01

0.12

1.5

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

885

1.04

0.12

1.3

1.1

mg/l

33.9

36.8

0.33

738

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

278

1.08

0.12

1.2

1.1

—

(40758558) Short blood count panel - Blood

2152

21387

1.01

0.12

6.0

6.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.16

0.11

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

260

1.08

0.10

1.6

1.7

ug/l

9.7

8.4

0.78

260

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

444

0.95

0.10

1.5

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

678

0.96

0.10

1.8

2.1

13.2

0.00

343

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.14

0.10

1.2

1.9

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.14

0.10

1.2

1.8

0.3

0.2

—

(4212803)

1.14

0.10

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.11

0.09

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

106

1.13

0.09

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.09

0.09

1.0

u/l

23.0

53.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

375

3696

1.02

0.09

1.6

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

242

1.07

0.09

3.5

4.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

114

0.88

0.09

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

301

1.06

0.09

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

361

3559

1.01

0.09

2.1

2.0

—

(40768443) Skin Pathology biopsy report

378

3728

1.01

0.09

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

121

1179

1.03

0.09

1.9

1.6

iu/ml

29.6

32.9

0.18

(3007463) Buprenorphine [Presence] in Urine

1.09

0.08

2.5

6.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

165

1.09

0.08

1.3

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.07

0.08

1.0

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

826

8191

1.01

0.08

1.7

—

(4198724)

410

1.05

0.08

1.8

2.7

—

(3050794) Legionella sp Ab [Presence] in Serum

0.82

0.08

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

389

0.95

0.08

1.6

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

179

1756

1.02

0.08

1.1

au/ml

7.4

11.8

—

117

(3017509) Phencyclidine [Presence] in Urine

123

0.89

0.08

1.1

1.6

—

(3035880) pH of Pleural fluid

205

0.93

0.08

1.5

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.03

0.07

1.0

1.5

pmol/l

8.4

18.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.12

0.07

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.81

0.07

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

256

2597

0.99

0.07

1.3

1.4

u/l

25.2

29.4

1.37

212

2114

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

318

3140

1.01

0.07

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

286

0.94

0.07

1.5

1.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

442

1.04

0.07

1.7

1.4

e6/l

1506.5

2594.1

1.25

312

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

601

1.03

0.06

1.3

g/l

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.11

0.06

1.0

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.11

0.06

1.8

2.0

umol/l

1.3

0.50

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

305

1.05

0.06

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

193

0.93

0.06

1.4

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1346

13521

0.99

0.06

2.4

2.7

mmol/l

2.4

0.07

1175

11810

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

162

0.93

0.06

1.1

1.0

—

(44790048)

741

1.03

0.06

1.5

—

(44806118)

741

1.03

0.06

1.5

—

(44790049)

741

1.03

0.06

1.5

—

(44790047)

741

1.03

0.06

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

375

0.96

0.05

1.1

1.0

ng/l

46.1

43.4

0.15

270

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

131

0.92

0.05

1.8

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

1.11

0.05

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

742

1.02

0.05

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

267

1.05

0.05

3.6

2.9

ng/l

74.4

94.9

0.30

106

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

544

1.03

0.05

1.3

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

808

0.98

0.05

1.2

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

144

1418

1.02

0.05

1.3

u/ml

16.3

60.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

333

0.96

0.05

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

189

1.06

0.04

1.2

g/l

35.8

38.1

0.21

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

429

4259

1.01

0.04

1.8

1.6

mg/l

3.7

3.2

1.18

326

2914

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

373

0.97

0.04

1.1

1.0

ng/l

655.8

758.3

0.72

270

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

377

1.03

0.04

1.6

1.7

umol/l

30.8

30.5

0.06

367

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

140

1.07

0.04

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

115

1133

1.02

0.04

1.8

1.5

—

(40768804) Tissue Pathology biopsy report

3860

38655

1.00

0.03

2.0

—

(3019977) pH of Arterial blood

299

1.04

0.03

1.6

2.9

7.4

1.43

(3052592) Norovirus Ag [Presence] in Stool

121

1.07

0.03

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

746

1.02

0.03

1.1

1.2

—

(4035726)

723

7199

1.00

0.03

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

189

0.95

0.03

1.8

3.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

189

0.95

0.03

1.8

3.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

668

1.02

0.03

1.2

1.3

titre

207.5

181.6

0.09

124

(3023383) Lactate [Moles/volume] in Pleural fluid

112

1.07

0.03

1.3

1.2

mmol/l

2.8

3.4

0.54

101

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

261

1.03

0.02

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

309

0.97

0.02

1.1

—

(3002619) Bacteria identified in Specimen by Culture

162

1.05

0.02

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

182

1.04

0.02

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

579

5773

1.00

0.02

1.5

—

(3001556) Androgen free Index in Serum or Plasma

117

0.94

0.01

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

701

1.01

0.01

5.3

6.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

759

0.99

0.01

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

337

0.98

0.01

1.5

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

326

0.98

0.00

1.7

2.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

344

1.02

0.00

1.1

u/ml

0.2

1.9

1.81

188

(3014599) Egg white IgE Ab [Units/volume] in Serum

736

0.99

0.00

1.0

u/ml

0.6

0.9

0.43

161

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.03

0.00

2.5

1.3

24.3

26.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

223

0.99

0.00

1.3

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

104

0.96

0.00

3.3

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

136

1.03

0.00

1.0

u/ml

0.0

—

(3011288) Drugs identified in Urine by Screen method

289

2893

1.00

0.00

2.6

2.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

165

1.03

0.00

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

195

1.03

0.00

1.3

1.4

nmol/l

94.6

111.2

0.48

143

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

315

0.98

0.00

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

202

0.99

0.00

1.7

2.2

e6/l

333.1

951.5

1.73

125

(3000060) B lymphocytes [#/volume] in Blood

282

0.99

0.00

1.8

2.2

e6/l

132.5

180.5

0.46

150

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

372

0.99

0.00

1.1

1.0

ng/l

1381.7

345.0

0.51

274

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

662

1.00

0.00

1.5

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

638

1.00

0.00

1.9

2.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

521

1.00

0.00

1.7

1.5

promille

0.8

1.3

1.51

397

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

651

1.00

0.00

1.4

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

759

1.00

0.00

1.1

iu/ml

5.0

7.6

0.82

209

(3023410) Appearance of Cerebral spinal fluid

961

1.00

0.00

1.3

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

111

0.99

0.00

1.5

2.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.90

0.00

1.2

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

3.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

301.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

29.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.3

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

180

1.00

0.00

1.4

2.0

e6/l

3077.0

19231.5

0.69

(1175426) CD3 cells/100 lymphocytes in Blood

690

1.00

0.00

1.8

2.1

77.0

75.0

0.87

665

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.97

0.00

7.3

6.0

umol/l

0.5

0.3

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.93

0.00

1.0

1.6

—

(3022475) Manganese [Moles/volume] in Blood

0.94

0.00

1.3

1.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027020) Pear IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

20.6

—

(40758358) Immune stain study

0.93

0.00

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint O15_PRE_OR_ECLAMPSIA and mortality.

Females

Parameter	HR [95% CI]	p-value
O15_PRE_OR_ECLAMPSIA	0.758 [0.63, 0.92]	0.004
Birth year	0.999 [0.99, 1.01]	0.833

During the follow-up period (1.1.1998 — 31.12.2019), 173 out of 28606 females with O15_PRE_OR_ECLAMPSIA died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_PRE_OR_ECLAMPSIA.

N-year risk	Females	Males
1	0.079%	No data
5	0.491%	No data
10	1.176%	No data
15	2.394%	No data
20	4.323%	No data

Relationships between endpoints

↥

Index endpoint: O15_PRE_OR_ECLAMPSIA – Pre-eclampsia or eclampsia

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pre-eclampsia or eclampsia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints